Boston Scientific (NYSE: BSX)+
announced today that it received FDA approval for its Farapulse pulsed field ablation (PFA) system.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,